摘要 |
The present invention relates to crystalline forms of the mono-sodium salt of D- isoglutamyl-D-tryptophan, pharmaceutical compositions comprising them, their use in the treatment of various diseases and conditions, and processes for their preparation. In particular, the present invention relates the crystal modification 1 (polymorphic form F), the crystal modification 2 (polymorphic form I), and the crystal modification 3 (polymorphic form X) of the mono-sodium salt of D-isoglutamyl-D-tryptophan. |
申请人 |
APOTEX TECHNOLOGIES INC.;TAM, TIM, FAT;N'ZEMBA, BLAISE;LEUNG-TOUNG, REGIS;WANG, YINGSHENG;ZHAO, YANQING;YU, LILY |
发明人 |
TAM, TIM, FAT;N'ZEMBA, BLAISE;LEUNG-TOUNG, REGIS;WANG, YINGSHENG;ZHAO, YANQING;YU, LILY |